Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

G1 Therapeutics Inc (NQ: GTHX )

20.50 USD -0.33 (-1.58%)
Streaming Delayed Price Updated: 4:07 AM EST, Jan 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about G1 Therapeutics Inc

< Previous 1 2 3 4 5 6 Next >
Peek Under The Hood: IEIH Has 17% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
First Week of February 2021 Options Trading For G1 Therapeutics (GTHX)
Investors in G1 Therapeutics Inc (GTHX) saw new options begin trading this week, for the February 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GTHX... 
Tags Stocks
From Market News Video
The Daily Biotech Pulse: Key Vaccine Adcom Review For Pfizer-BioNTech, Puma, Immutep, G1 Rally On Breast Cancer Conference Presentations
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags PBYI Penny Stocks HBIO
From Benzinga
The Daily Biotech Pulse: Roche & Moderna Strike COVID Testing Partnership, Rocket Pharma's Gene Therapy Readout, Breast Cancer Presentations
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ASMB RARE LLY
From Benzinga
Week Ahead In Biotech: FDA To Decide On Emergency Use Of Pfizer's COVID Vaccine, Hematology Conference Presentations Pick Up Pace
Biotech stocks headed higher in the week ended Dec. 5 as broader market optimism pervaded into the sector. The sector also continued to ... 
Tags IMV PGEN CTIC
From Benzinga
70 Biggest Movers From Yesterday
Gainers China Automotive Systems, Inc. (NASDAQ: CAAS) shares surged 174.2% to close at $10.50 on Monday after the company ... 
Tags GTHX NNOX KNDI
From Benzinga
Mid-Day Market Update: Crude Oil Down Over 1%; Nikola Shares Plunge
Midway through trading Monday, the Dow traded down 1.21% to 29,547.12 while the NASDAQ fell 0.50% to 12,145.24. The S&P also fell, ... 
Tags Market News Earnings News
From Benzinga
46 Stocks Moving In Monday's Mid-Day Session
Gainers China Automotive Systems, Inc. (NASDAQ: CAAS) shares jumped 60% to $6.13 after the company announced a significant ... 
Tags NM SNDL MSTR
From Benzinga
Bullish Two Hundred Day Moving Average Cross - GTHX
In trading on Monday, shares of G1 Therapeutics Inc (GTHX) crossed above their 200 day moving average of $15.41, changing hands as high as $17.74 per share. G1 Therapeutics Inc shares are currently... 
Tags Stocks
From Market News Video
Return On Capital Employed Overview: G1 Therapeutics
During Q3, G1 Therapeutics (NASDAQ: GTHX) brought in sales totaling $26.60 million. However, earnings decreased 68.38%, resulting in a ... 
Tags News Earnings Benzinga
From Benzinga
Mid-Morning Market Update: Markets Open Lower; S&P Global To Buy IHS Markit For $44B
Following the market opening Monday, the Dow traded down 0.95% to 29,626.44 while the NASDAQ fell 0.12% to 12,190.71. The S&P also ... 
Tags GTHX Intraday Update Eurozone
From Benzinga
Last Week's Notable Insider Buys: Avis, Biglari And More
Insider buying can be an encouraging signal for potential investors when markets face uncertainty. This past week, some insiders ... 
Tags SBH Sardar Biglari Keros Therapeutics
From Benzinga
Implied LABU Analyst Target Price: $102
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags LYRA SYK DVAX
From Benzinga
Recap: G1 Therapeutics Q3 Earnings
Shares of G1 Therapeutics (NASDAQ:GTHX) rose 2.7% in after-market trading after the company reported Q3 results. Quarterly ... 
Tags Earnings Market News Benzinga
From Benzinga
The Daily Biotech Pulse: Alzheimer's Conference Underway, Biogen's Aducanumab Briefing Doc, Supernus Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags AXNX SLN UTHR
From Benzinga
The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
Biotech stocks continued to sway to the tunes of the broader market in the week ended Oct. 30, which succumbed to geopolitical and ... 
Tags ADMA News INMB
From Benzinga
How The Parts Add Up: IWO Targets $274
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Interesting GTHX Put And Call Options For December 18th
Investors in G1 Therapeutics Inc (GTHX) saw new options become available this week, for the December 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GTHX... 
Tags Stocks
From Market News Video
12 Healthcare Stocks Moving In Friday's After-Market Session
Gainers Collegium Pharmaceutical (NASDAQ:COLL) stock surged 6.32% to $23.7 during Friday's after-market session. This security ... 
Tags After/Hours Center CHMA PHAS
From Benzinga
The Daily Biotech Pulse: Amag Spikes On Takeover Rumors, Zosano Wilts On Regulatory Setback, Pulmonx Makes Wall Street Debut
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags IPOs PODD Benzinga
From Benzinga
The Math Shows XBI Can Go To $161
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Analysts Anticipate 12% Upside For VTWO
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
42 Stocks Moving in Tuesday's Pre-Market Session
Gainers Forward Industries, Inc. (NASDAQ: FORD) shares rose 81.8% to $2.49 in pre-market trading after the company said it ... 
Tags NMTR IGC CHU
From Benzinga
76 Biggest Movers From Yesterday
Gainers LMP Automotive Holdings, Inc. (NASDAQ: LMPX) shares surged 69.7% to close at $11.81 on Monday following Q2 results. The ... 
Tags LAC Packaged Foods & Meats News
From Benzinga
60 Stocks Moving In Monday's Mid-Day Session
Gainers Stein Mart, Inc. (NASDAQ: SMRT) shares climbed 87.4% to $0.2050 after dropping 11% on Friday. Stein Mart, last week, ... 
Tags TRMD PEIX REDU
From Benzinga
46 Stocks Moving in Monday's Pre-Market Session
Gainers Stein Mart, Inc. (NASDAQ: SMRT) shares rose 93.8% to $0.2120 in pre-market trading after dropping 11% on Friday. Stein ... 
Tags JAGX Movers CTK
From Benzinga
Week In Review: BioKangtai Acquires China Rights To AstraZeneca's COVID-19 Vaccine
BioKangtai, a Guangdong vaccine company, in-licensed rights to develop, manufacture, and market AstraZeneca's COVID-19 vaccine in China. Biogen announced a $2 billion deal to partner Denali... 
Tags Healthcare Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
Week in Review: BioKangtai Acquires China Rights to AstraZeneca's COVID-19 Vaccine
COVID-19 Pandemic • BioKangtai, a Guangdong vaccine company, in-licensed rights to develop, manufacture and market AstraZeneca's COVID-19 vaccine in China; • Shanghai Fosun Pharma has dosed the first... 
From ChinaBio® Today
G1 Therapeutics, Inc. (GTHX) Q2 2020 Earnings Call Transcript
GTHX earnings call for the period ending June 30, 2020. 
Tags Market News GTHX
From Motley Fool
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.